keyword
https://read.qxmd.com/read/38647876/increase-of-prostate-specific-antigen-doubling-time-predicts-survival-in-metastatic-castration-resistant-prostate-cancer-patients-undergoing-radium-therapy
#21
JOURNAL ARTICLE
Hsi-Huei Lu, Nan-Tsing Chiu, Mu-Hung Tsai
OBJECTIVE: Radium-223 (Ra-223) is an important treatment modality for bone-dominant metastatic castration-resistant prostate cancer (mCRPC). However, there is currently a lack of effective markers to monitor treatment response during treatment. We aim to investigate the response in prostate-specific antigen doubling time (PSADT) as a potential marker for assessing Ra-223 treatment in mCRPC patients. METHODS: We retrospectively collected data from mCRPC patients who underwent radium treatment at our institution between August 2020 and June 2023...
April 22, 2024: Annals of Nuclear Medicine
https://read.qxmd.com/read/38646651/programming-peptide-oligonucleotide-nano-assembly-for-engineering-of-neoantigen-vaccine-with-potent-immunogenicity
#22
JOURNAL ARTICLE
Zhichu Xiang, Jianhua Lu, Shangrui Rao, Chenxing Fu, Yuying Yao, Yongdong Yi, Yang Ming, Weijian Sun, Weisheng Guo, Xiaoyuan Chen
Background: Neoantigen nanovaccine has been recognized as a promising treatment modality for personalized cancer immunotherapy. However, most current nanovaccines are carrier-dependent and the manufacturing process is complicated, resulting in potential safety concerns and suboptimal codelivery of neoantigens and adjuvants to antigen-presenting cells (APCs). Methods: Here we report a facile and general methodology for nanoassembly of peptide and oligonucleotide by programming neoantigen peptide with a short cationic module at N-terminus to prepare nanovaccine...
2024: Theranostics
https://read.qxmd.com/read/38646643/exploring-the-role-of-combined-external-beam-radiotherapy-and-targeted-radioligand-therapy-with-177-lu-lu-psma-617-for-prostate-cancer-from-bench-to-bedside
#23
JOURNAL ARTICLE
Daria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, Lisa-Charlotte Domogalla, Nils Steinacker, Michael Mix, Gabriele Niedermann, Simon K B Spohn, Martin T Freitag, Anca L Grosu, Philipp T Meyer, Christian Gratzke, Matthias Eder, Constantinos Zamboglou, Ann-Christin Eder
Management of prostate cancer (PC) might be improved by combining external beam radiotherapy (EBRT) and prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) with lutetium-177 (177 Lu)-labeled PSMA inhibitors. We hypothesized a higher efficacy of the combination due to augmentation of the radiation dose to the tumor and interactions of EBRT with PSMA expression potentially increasing radiopharmaceutical uptake. Therefore, this study analyzed the influence of radiation on PSMA expression levels in vitro ...
2024: Theranostics
https://read.qxmd.com/read/38646223/post-mastectomy-pain-syndrome-a-review-article-and-emerging-treatment-modalities
#24
REVIEW
Jay D Shah, Kennedy Kirkpatrick, Krishna Shah
Post-mastectomy pain syndrome (PMPS) is a syndrome broadly applied to the development of chronic pain after surgical breast intervention (i.e., lumpectomy and mastectomy). The incidence of PMPS is likely underreported, and this has contributed to a paucity of high-level evidence related to the treatment of the aforementioned condition. A drive to reduce the burden of opioid use has led to pain management physicians trialing a variety of strategies to help patients manage PMPS. This review discusses the latest evidence behind treatment options for PMPS, exploring medications as well as interventional techniques (e...
March 2024: Curēus
https://read.qxmd.com/read/38645527/current-status-of-controlled-onco-therapies-based-on-metal-organic-frameworks
#25
REVIEW
Yixuan Yang, Xiaofeng Dai
Despite consecutive efforts devoted to the establishment of innovative therapeutics for cancer control, cancer remains as a primary global public health concern. Achieving controlled release of anti-cancer agents may add great value to the field of oncology that requires the involvement of nanotechnologies. Metal organic frameworks (MOFs) hold great promise in this regard owing to their unique structural properties. MOFs can act as superior candidates for drug delivery given their porous structure and large loading area, and can be prepared into anti-cancer therapeutics by incorporating stimuli-sensitive components into the ligands or nodes of the framework...
April 16, 2024: RSC Advances
https://read.qxmd.com/read/38645088/multi-scale-in-vivo-imaging-of-tumour-development-using-a-germline-conditional-triple-reporter-system
#26
Piotr Dzien, Ximena Raffo Iraolagoitia, Stephanie May, David Stevenson, Lynn McGarry, Dmitry Soloviev, Gavin Brown, Colin Nixon, Chrysa Kapeni, Maike De La Roche, Karen Blyth, Scott Lyons, Thomas Bird, Douglas Strathdee, Gilbert Fruhwirth, Leo Carlin, David Lewis
Imaging reporter genes are indispensable for visualising biological processes in living subjects, particularly in cancer research where they have been used to observe tumour development, cancer cell dissemination, and treatment response. Engineering reporter genes into the germline frequently involves single imaging modality reporters operating over limited spatial scales. To address these limitations, we developed an inducible triple-reporter mouse model (Rosa26 LSL - NRL ) that integrates reporters for complementary imaging modalities, fluorescence, bioluminescence and positron emission tomography (PET), along with inducible Cre-lox functionality for precise spatiotemporal control of reporter expression...
April 3, 2024: Research Square
https://read.qxmd.com/read/38644915/surgical-management-of-spinal-metastases-from-primary-thyroid-carcinoma-demographics-clinical-characteristics-and-treatment-outcomes-a-retrospective-analysis
#27
JOURNAL ARTICLE
Rahul Kishore Chaliparambil, Mykhaylo Krushelnytskyy, Nathan A Shlobin, Vineeth Thirunavu, Anastasios G Roumeliotis, Collin Larkin, Hanna Kemeny, Najib El Tecle, Tyler Koski, Nader S Dahdaleh
OBJECTIVE: Metastatic spinal tumors represent a rare but concerning complication of primary thyroid carcinoma. We identified demographics, metastatic features, outcomes, and treatment strategies for these tumors in our institutional cohort. MATERIALS AND METHODS: We retrospectively reviewed patients surgically treated for spinal metastases of primary thyroid carcinoma. Demographics, tumor characteristics, and treatment modalities were collected. The functional outcomes were quantified using Nurik, Modified Rankin, and Karnofsky Scores...
2024: Journal of Craniovertebral Junction and Spine
https://read.qxmd.com/read/38644342/a-carbon-caged-rhodamine-generating-nitrosoperoxycarbonate-for-photoimmunotherapy
#28
JOURNAL ARTICLE
Lei Yin, Bei Zhao, Jie Zhou, Yunxia Huang, Hao Ma, Ting Zhou, Jie Mou, Peiru Min, Jinquan Chen, Guangbo Ge, Xuhong Qian, Xiao Luo, Youjun Yang
Photoimmunotherapy is a promising cancer treatment modality. While potent 1-e- oxidative species are known to induce immunogenic cell death (ICD), they are also associated with unspecific oxidation and collateral tissue damage. This difficulty may be addressed by post-generation radical reinforcement. Namely, non-oxidative radicals are first generated and subsequently activated into powerful oxidative radicals to induce ICD. Here, we developed a photo-triggered molecular donor (NPCD565) of nitrosoperoxycarbonate (ONOOCO2-), the first of its class to our knowledge, and further evaluated its feasibility for immunotherapy...
April 21, 2024: Angewandte Chemie
https://read.qxmd.com/read/38644239/-organ-preservation-and-watch-and-wait-strategy-in-esophageal-cancer-a-promising-future
#29
JOURNAL ARTICLE
H Jiao, L J Tan
The traditional treatment modalities for esophageal cancer include surgery, chemotherapy, and radiotherapy, each presenting its own limitations. With advancements in endoscopic techniques and the integration of immunotherapy, the feasibility and safety of organ preservation have significantly improved, offering patients improved survival and quality of life. The selection of patients suitable for organ preservation treatment demands ongoing exploration. Those selected for this approach require rigorous monitoring, with surgical intervention as a salvation for tumor progression or metastasis, though the timing of surgery remains a topic of debate...
April 25, 2024: Zhonghua Wei Chang Wai Ke za Zhi, Chinese Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38642218/cancer-population-norms-using-a-new-value-set-for-the-sf-6dv2-based-on-the-preferences-of-patients-with-breast-or-colorectal-cancer-in-quebec
#30
JOURNAL ARTICLE
Moustapha Touré, Sarah-Maria Sfairy, Suzanne K Bédard, Nathalie McFadden, Robert Hanel, Frédéric Lemay, Jie He, Michel Pavic, Thomas G Poder
BACKGROUND: Because health resources are limited, health programs should be compared to allow the most efficient ones to emerge. To that aim, health utility instruments have been developed to allow the calculation of quality-adjusted life-year (QALY). However, generic instruments, which can be used by any individual regardless of their health profile, typically consider the preferences of the general population when developing their value set. Consequently, they are often criticized for lacking sensitivity in certain domains, such as cancer...
April 20, 2024: Quality of Life Research
https://read.qxmd.com/read/38642125/surgical-management-of-rectal-cancer-with-synchronous-treatment-of-prostate-cancer
#31
JOURNAL ARTICLE
Raphaëlle Brière, André-Guy Martin, François Letarte, François Rouleau Fournier, Philippe Bouchard, Sébastien Drolet
PURPOSE: To assess the safety and efficacy of synchronous treatments for rectal (RC) and prostate (PC) cancers. METHODS: Single-center retrospective study (2007-2021) of patients treated with neoadjuvant radiotherapy (RT) and total mesorectal excision (TME) for RC with synchronous PC treatment. The endpoints were 30-day postoperative severe complications, R0 resection rates, 3-year disease-free survival (DFS) and 3-year overall survival (OS). RESULTS: Among the 16 patients, 15 (93...
April 20, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38642071/cascade-nanoreactor-employs-mitochondrial-directed-chemodynamic-and-%C3%AE-ala-mediated-photodynamic-synergy-for-deep-seated-oral-cancer-therapy
#32
JOURNAL ARTICLE
Qiqi Yin, Yanli Yao, Handan Zhang, Jie Zhang, Jiaming Gao, Lin Weng, Tao Liu, Shuyang Sun, Xin Chen
The management of oral squamous cell carcinoma (OSCC) poses significant challenges, leading to organ impairment and ineffective treatment of deep-seated tumors, adversely affecting patient prognosis. We introduced a cascade nanoreactor that integrates photodynamic therapy (PDT) and chemodynamic therapy (CDT) for comprehensive multimodal OSCC treatment. Utilizing iron oxide nanoparticles and mesoporous silica, we developed the FMMSH drug delivery system, encapsulating the photosensitizer prodrug δ-aminolevulinic acid (δ-ALA)...
April 20, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38642044/intelligent-biogenic-missile-for-two-photon-fluorescence-imaging-guided-combined-photodynamic-therapy-and-chemotherapy-in-tumors
#33
JOURNAL ARTICLE
Zhiling Qian, Kangdi He, Rong Feng, Jia Chen, Bingqian Li, Yuhang Zhang, Shengrong Yu, Keqi Tang, Ning Gan, Yong-Xiang Wu
Photodynamic therapy (PDT) is a significant noninvasive therapeutic modality, but it is often limited in its application due to the restricted tissue penetration depth caused by the wavelength limitations of the light source. Two-photon (TP) fluorescence techniques are capable of having an excitation wavelength in the NIR region by absorbing two NIR photons simultaneously, which offers the potential to achieve higher spatial resolution for deep tissue imaging. Thus, the adoption of TP fluorescence techniques affords several discernible benefits for photodynamic therapy...
April 20, 2024: Analytical Chemistry
https://read.qxmd.com/read/38641651/multiparametric-mri-for-characterization-of-the-tumour-microenvironment
#34
REVIEW
Emily Hoffmann, Max Masthoff, Wolfgang G Kunz, Max Seidensticker, Stefanie Bobe, Mirjam Gerwing, Wolfgang E Berdel, Christoph Schliemann, Cornelius Faber, Moritz Wildgruber
Our understanding of tumour biology has evolved over the past decades and cancer is now viewed as a complex ecosystem with interactions between various cellular and non-cellular components within the tumour microenvironment (TME) at multiple scales. However, morphological imaging remains the mainstay of tumour staging and assessment of response to therapy, and the characterization of the TME with non-invasive imaging has not yet entered routine clinical practice. By combining multiple MRI sequences, each providing different but complementary information about the TME, multiparametric MRI (mpMRI) enables non-invasive assessment of molecular and cellular features within the TME, including their spatial and temporal heterogeneity...
April 19, 2024: Nature Reviews. Clinical Oncology
https://read.qxmd.com/read/38641624/study-protocol-assessing-parkrun-for-walking-rehabilitation-for-people-living-with-and-beyond-cancer-acceptability-adherence-social-support-and-physical-function
#35
JOURNAL ARTICLE
Suzanne Broadbent, Robert Buhmann, Yuri Kriel, Sonja Coetzee, Christian Jones, Michelle Morris, Hattie H Wright
INTRODUCTION: Due to a variety of barriers, the majority of cancer survivors do not do enough physical activity to meet current recommendations. This study will assess the feasibility of participation in parkrun walk-run events as a novel mode of community rehabilitation exercise. METHODS: This protocol describes a single-arm intervention study with participants acting as their own controls. The study accepts adults diagnosed with any type of cancer, undergoing treatment or in remission...
April 19, 2024: BMC Sports Science, Medicine and Rehabilitation
https://read.qxmd.com/read/38640714/prospects-and-challenges-of-car-t-in-the-treatment-of-ovarian-cancer
#36
REVIEW
Biqing Chen, Jiaqi Liu
Ovarian cancer ranks as the seventh most prevalent cancer among women and is considered the most lethal gynecological malignancy on a global scale. The absence of reliable screening techniques, coupled with the insidious onset of nonspecific symptoms, often results in a delayed diagnosis, typically at an advanced stage characterized by peritoneal involvement. Management of advanced tumors typically involves a combination of chemotherapy and cytoreductive surgery. However, the therapeutic arsenal for ovarian cancer patients remains limited, highlighting the unmet need for precise, targeted, and sustained-release pharmacological agents...
April 18, 2024: International Immunopharmacology
https://read.qxmd.com/read/38639918/a-machine-learning-algorithm-facilitates-prognosis-prediction-and-treatment-selection-for-barcelona-clinic-liver-cancer-stage-c-hepatocellular-carcinoma
#37
JOURNAL ARTICLE
Ji Won Han, Soon Kyu Lee, Jung Hyun Kwon, Soon Woo Nam, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, U Im Chang, Do Seon Song, Seok-Hwan Kim, Myeong Jun Song, Pil Soo Sung, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
BACKGROUND: Given its heterogeneity and diverse clinical outcomes, precise subclassification of BCLC-C hepatocellular carcinoma (HCC) is required for appropriately determining patient prognosis and selecting treatment. METHODS: We recruited 2,626 patients with BCLC-C stage HCC from multiple centers, comprising training/test (n=1,693) and validation cohorts (n=933). The XGBoost was chosen for maximum performance among the machine learning (ML) models. Patients were categorized into low-/intermediate-/high-/very high-risk subgroups which were based on the estimated prognosis, and this subclassification was named the CLAssification via Machine learning of BCLC-C (CLAM-C)...
April 19, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38639607/efficacy-and-safety-of-recombinant-human-p53-adenovirus-injection-combined-with-radiotherapy-or-concurrent-chemoradiotherapy-in-the-treatment-of-cervical-cancer-a-systematic-review-and-meta-analysis
#38
JOURNAL ARTICLE
Guangshu Zhang, Guizhen Su
OBJECTIVE: Cervical cancer remains a major health concern globally, and combined modality treatment often includes radiotherapy or concurrent chemoradiotherapy. Recently, recombinant human adenovirus-p53 (rAd-p53) has been introduced as a promising agent in treatment of cervical cancer. METHODS: We conducted a systematic review and meta-analysis following the PRISMA guidelines. RCTs were identified through electronic databases without limitations on time or language...
April 18, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38639331/the-role-of-extracellular-vesicles-in-the-treatment-of-prostate-cancer
#39
REVIEW
Cong Hu, Qi Chen, Tianyang Wu, Xinxing Du, Yanhao Dong, Zehong Peng, Wei Xue, Vijaya Sunkara, Yoon-Kyoung Cho, Liang Dong
Prostate cancer (PCa) has become a public health concern in elderly men due to an ever-increasing number of estimated cases. Unfortunately, the available treatments are unsatisfactory because of a lack of a durable response, especially in advanced disease states. Extracellular vesicles (EVs) are lipid-bilayer encircled nanoscale vesicles that carry numerous biomolecules (e.g., nucleic acids, proteins, and lipids), mediating the transfer of information. The past decade has witnessed a wide range of EV applications in both diagnostics and therapeutics...
April 19, 2024: Small
https://read.qxmd.com/read/38638858/tumor-regression-and-safe-distance-of-distal-margin-after-neoadjuvant-therapy-for-rectal-cancer
#40
REVIEW
Guilin Yu, Huanyu Chi, Guohua Zhao, Yue Wang
Neoadjuvant therapy has been widely employed in the treatment of rectal cancer, demonstrating its utility in reducing tumor volume, downstaging tumors, and improving patient prognosis. It has become the standard preoperative treatment modality for locally advanced rectal cancer. However, the efficacy of neoadjuvant therapy varies significantly among patients, with notable differences in tumor regression outcomes. In some cases, patients exhibit substantial tumor regression, even achieving pathological complete response...
2024: Frontiers in Oncology
keyword
keyword
49035
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.